SIREN : 339787962
ALPHAMED is a French company founded 39 years ago, specialized in the sector Gestion de fonds. Based in PARIS (75017), this company of category GE shows in 2025 a net income negative of -7.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | -7 890 599 € | -2 252 461 € | -13 320 481 € | -6 078 377 € | 5 033 935 € | -12 038 146 € | -12 038 146 € | 719 951 € |
| EBITDA | -1 377 084 € | -1 313 430 € | -1 593 055 € | -1 370 502 € | -1 509 890 € | -1 249 359 € | -1 249 352 € | -1 771 411 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C | N/C |
In 2025, ALPHAMED records a net loss of 7.9 M€. This deficit will reduce equity on the balance sheet.
-1 377 084 €
-1 377 083 €
-7 890 599 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 73%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.
0.038%
73.48%
0.038
In 2025, the debt ratio of ALPHAMED (0.04) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2025, the financial autonomy of ALPHAMED (73.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2025, the repayment capacity of ALPHAMED (0.04) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 444.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
444.102
-747.358
In 2025, the liquidity ratio of ALPHAMED (444.10) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2025, the interest coverage of ALPHAMED (-747.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 15 days. Favorable situation: supplier credit is longer than customer credit by 15 days.
0 €
0 j
15 j
0 j
Compare ALPHAMED with other companies in the same sector:
The revenue of ALPHAMED is not publicly disclosed (confidential accounts filed with INPI).
ALPHAMED recorded a net loss in 2025.
The headquarters of ALPHAMED is located in PARIS (75017), in the department Paris.
The tax return of ALPHAMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ALPHAMED operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.